10:32 , Apr 22, 2019 |  BC Extra  |  Company News

Lilly pays $35M up front to partner with Avidity on oligo conjugates

Lilly partnered with Avidity to develop antibody-oligonucleotide conjugates to treat immune diseases, with the biotech receiving $20 million up front and a $15 million investment. Avidity Biosciences LLC (La Jolla, Calif.) is eligible to receive...
20:45 , Feb 8, 2019 |  BC Week In Review  |  Company News

Verily launches OneFifteen to create tech-forward solutions for addiction

Verily Life Sciences LLC (South San Francisco, Calif.) launched OneFifteen, a not-for-profit healthcare "ecosystem" that includes clusters for innovators to develop technology-enabled solutions for patients suffering from opioid addiction. Verily said it will develop a...
00:53 , Sep 15, 2018 |  BioCentury  |  Politics, Policy & Law

Debating diagnostics

Instead of perpetuating a decades-old dispute about whether FDA can and should regulate laboratory-derived tests, the agency and test makers have moved on to conversations about how FDA should do so, and from threats of...
18:54 , Jul 13, 2018 |  BC Week In Review  |  Financial News

With $132M series A, Compass points toward the clinic

Bispecific antibody play Compass Therapeutics LLC (Cambridge, Mass.) raised $49 million on July 12 in the final tranche of its series A round, bringing the round's total to $132 million. OrbiMed Advisers led the round....
15:35 , Jul 12, 2018 |  BC Extra  |  Financial News

With $132M series A, Compass points toward the clinic

Bispecific antibody play Compass Therapeutics LLC (Cambridge, Mass.) raised $49 million Thursday in the final tranche of its series A round, bringing the round's total to $132 million. OrbiMed Advisers led the round. F-Prime Capital...
13:48 , Apr 13, 2018 |  BC Week In Review  |  Company News

Alexandria LaunchLabs expanding to Cambridge, Mass.

Alexandria Real Estate Equities Inc. (NYSE:ARE) said it will expand Alexandria LaunchLabs to Cambridge, Mass. LaunchLabs is designed to provide life science start-ups with office space, equipment, amenities and access to investment capital. Last year,...
04:19 , Apr 12, 2018 |  BC Extra  |  Financial News

Alexandria LaunchLabs expanding to Cambridge, Mass.

Alexandria Real Estate Equities Inc. (NYSE:ARE) said it will expand Alexandria LaunchLabs to Cambridge, Mass. LaunchLabs is designed to provide life science start-ups with office space, equipment, amenities and access to investment capital. Last year,...
18:52 , Mar 15, 2018 |  BC Innovations  |  Tools & Techniques

Shared burden

Having learned their lesson with PD-L1, companies are collaborating on assay standards for tumor mutation burden -- a likely contender for the next major biomarker in immuno-oncology. A Friends of Cancer Research-led consortium of pharmas...
16:03 , Mar 15, 2018 |  BC Extra  |  Company News

Arbor launches with $15.6 million, new CRISPR enzyme

Arbor Biotechnologies Inc. (Cambridge, Mass.) emerged from stealth mode on Thursday with a study detailing the discovery of a new CRISPR enzyme, CRISPR-associated protein 13d (Cas13d), and a $15.6 million series A round that closed...
16:38 , Jan 12, 2018 |  BC Week In Review  |  Financial News

Alexandria launches seed capital platform

Alexandria Venture Investments said on Jan. 7 it is continuing to boost its investment in early stage life science companies through the launch of the Alexandria Seed Capital Platform. Alexandria’s Jenna Foger told BioCentury the...